Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hepatitis × Prednisone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 101 Lymphoma, Large B-Cell, Diffuse 91 Lymphoma 78 Precursor Cell Lymphoblastic Leukemia-Lymphoma 51 Lymphoma, Follicular 35 Burkitt Lymphoma 34 Lymphoma, Non-Hodgkin 33 Leukemia 29 Multiple Myeloma 26 Hodgkin Disease 24 Lymphoma, Mantle-Cell 23 Lymphoma, T-Cell, Peripheral 18 Lymphoma, Large-Cell, Immunoblastic 15 Neoplasm Metastasis 13 Lymphoma, Large-Cell, Anaplastic 13 Lymphoma, B-Cell, Marginal Zone 13 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 11 Neoplasms, Plasma Cell 11 Lymphoma, B-Cell 11 Leukemia, Lymphocytic, Chronic, B-Cell 11 Immunoblastic Lymphadenopathy 10 Recurrence 9 Dendritic Cell Sarcoma, Interdigitating 8 Blast Crisis 7 Neoplasms 6 Enteropathy-Associated T-Cell Lymphoma 6 Waldenstrom Macroglobulinemia 5 Primary Myelofibrosis 5 Myasthenia Gravis 5 Leukemia, Myeloid, Acute 5

Interventions

Blood Specimen Collection 2 bavituximab 1 Ursodeoxycholic Acid 1 Surveys and Questionnaires 1 Steroids 1 Spermine Synthase 1 Sorafenib 1 Prednisone 1 Phlebotomy 1 Mycophenolic Acid 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Liquid Biopsy 1 Clinical Protocols 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡